As B cells strongly depend on BTK activity for function and survival, this protein has been used as a target for the development of small molecule inhibitors in B-cell malignancies and autoimmune disorders such as multiple sclerosis (MS), a chronic inflammatory disorder of the central nervous system (CNS) (5, 6). The gene discussed is BTK; the disease is myeloid sarcoma.